Industry: Chemical & Material
Published Date: 2025-05-30
Pages: 127 Pages
Report ld: 4747913
Request Sample
Customized Report
L-Glutamine (USP) Market Size(US$)

CAGR 2025-2031
4.5%
Market Size,2031
USD 254
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global L-Glutamine (USP) market is projected to grow from US$ 195 million in 2025 to US$ 254 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period.
The evolving U.S. tariff policy posed substantial volatility risks to global markets. This report provides a comprehensive assessment of trade barrier escalations and cross-border counterstrategies, analyzing their multidimensional impacts on industrial competition patterns, geo-economic integration, and transnational value chain realignments.
L-Glutamine (commonly abbreviated as Gln) is a conditionally essential amino acid that plays a pivotal role in numerous physiological functions, including protein synthesis, immune response, and gut health. Structurally classified among the 20 standard amino acids, L-Glutamine contains an amide group derived from glutamic acid. It is the most abundant free amino acid in the human body, primarily synthesized in skeletal muscles and transported via the bloodstream to various tissues that require it for metabolic processes. L-Glutamine is deemed conditionally essential because, under normal circumstances, the body produces adequate amounts. However, during times of physical stress, such as trauma, surgery, infection, or intense exercise, the demand for L-Glutamine can exceed the body’s capacity to produce it, necessitating external supplementation.
In commercial form, L-Glutamine is typically produced via microbial fermentation, most commonly using genetically modified strains of bacteria such as Corynebacterium glutamicum or Escherichia coli. The industrial process involves fermenting carbohydrates such as glucose or molasses, followed by purification steps to isolate the amino acid. L-Glutamine is usually available in powdered form but can also be found in capsules, tablets, and functional food products such as protein shakes and fortified bars.
The primary applications of L-Glutamine are found in nutraceuticals, clinical nutrition, sports supplements, functional foods, and animal feed additives. In the healthcare and medical nutrition sector, L-Glutamine is utilized for its therapeutic benefits in treating conditions such as short bowel syndrome, Crohn’s disease, and to mitigate the side effects of chemotherapy. In sports and fitness, it is a popular supplement among athletes and bodybuilders to enhance muscle recovery, reduce fatigue, and prevent muscle catabolism. Its benefits in improving gut barrier integrity and immune system function also make it a valued ingredient in wellness and dietary supplement markets.
L-Glutamine (USP) refers to the purified form of the amino acid L-glutamine.
The global L-Glutamine (USP) market has witnessed steady growth over the past decade, driven by increasing health consciousness, a growing sports nutrition industry, and heightened demand for immune-boosting products in the wake of the COVID-19 pandemic. The North American and Asia-Pacific regions dominate the market, with Europe following closely behind. Key contributors to growth include rising demand in China and India for both human and animal nutrition applications, as well as technological advancements in amino acid fermentation.
Key Market Drivers
Rising Demand for Nutritional Supplements
The increasing prevalence of lifestyle-related disorders such as obesity, diabetes, and cardiovascular disease has spurred consumer interest in preventive healthcare and nutritional supplementation. L-Glutamine (USP), with its multifunctional health benefits, fits well into the product portfolios of companies targeting these consumer needs. Additionally, growing awareness of the importance of gut health and immune support has further popularized glutamine supplementation.
Expanding Sports and Fitness Industry
The growth of the sports and fitness industry, driven by rising disposable income, increasing urbanization, and greater access to gyms and health clubs, has significantly influenced the L-Glutamine (USP) market. Athletes and fitness enthusiasts frequently incorporate glutamine supplements into their regimens to aid muscle recovery, reduce exercise-induced stress, and prevent muscle degradation, particularly in endurance sports or resistance training.
Therapeutic Applications in Clinical Nutrition
The use of L-Glutamine (USP) in medical nutrition therapy is another major growth driver. Hospitals and clinical settings use glutamine supplementation in enteral and parenteral nutrition for patients suffering from trauma, burns, or gastrointestinal disorders. Additionally, L-Glutamine (USP) has shown promising results in reducing mucositis in cancer patients undergoing chemotherapy or radiation therapy.
Shift Toward Preventive Healthcare
As healthcare systems worldwide move from treatment-centric to prevention-centric models, there has been a noticeable rise in demand for functional foods and dietary supplements. L-Glutamine (USP) fits into this trend due to its broad application across multiple wellness domains, including digestive health, metabolic health, and immune modulation.
Global L-Glutamine (USP) core manufacturers include Ajinomoto, Kyowa Hakko Kirin, Daesang, Meihua and Fufeng, etc. The top three manufacturers account for approximately 75% of the global share. The United States is the world's largest market, accounting for nearly 40% of the market.
In terms of production side, this report researches the L-Glutamine (USP) production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.
In terms of consumption side, this report focuses on the sales of L-Glutamine (USP) by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for L-Glutamine (USP), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of L-Glutamine (USP), also provides the consumption of main regions and countries. Highlights of the upcoming market potential for L-Glutamine (USP), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the L-Glutamine (USP) sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global L-Glutamine (USP) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for L-Glutamine (USP) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including MeiHua Holdings Group, Ajinomoto, Kyowa Hakko, Fufeng Group, Daesang, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: L-Glutamine (USP) production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of L-Glutamine (USP) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of L-Glutamine (USP) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, L-Glutamine (USP) sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 L-Glutamine (USP) Product Introduction
1.2 Market by Type
1.2.1 Global L-Glutamine (USP) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Food Grade
1.2.3 Pharmaceutical Grade
1.2.4 Others
1.3 Market by Application
1.3.1 Global L-Glutamine (USP) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Food and Beverages
1.3.3 Pharmaceutical Use
1.3.4 Nutraceutical Use
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global L-Glutamine (USP) Production
2.1 Global L-Glutamine (USP) Production Capacity (2020-2031)
2.2 Global L-Glutamine (USP) Production by Region: 2020 VS 2024 VS 2031
2.3 Global Production by Region
2.3.1 Global L-Glutamine (USP) Production by Region (2020-2031)
2.3.2 Global L-Glutamine (USP) Production Market Share by Region (2020-2031)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
2.8 Korea
3 Executive Summary
3.1 Global L-Glutamine (USP) Revenue Estimates and Forecasts 2020-2031
3.2 Global Revenue by Region
3.2.1 Global L-Glutamine (USP) Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global L-Glutamine (USP) Revenue by Region (2020-2031)
3.2.3 Global L-Glutamine (USP) Revenue Market Share by Region (2020-2031)
3.3 Global L-Glutamine (USP) Sales Estimates and Forecasts 2020-2031
3.4 Global Sales by Region
3.4.1 Global L-Glutamine (USP) Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global L-Glutamine (USP) Sales by Region (2020-2031)
3.4.3 Global L-Glutamine (USP) Sales Market Share by Region (2020-2031)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufacturers
4.1 Global Sales by Manufacturers
4.1.1 Global L-Glutamine (USP) Sales by Manufacturers (2020-2025)
4.1.2 Global L-Glutamine (USP) Sales Market Share by Manufacturers (2020-2025)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of L-Glutamine (USP) in 2024
4.2 Global Revenue by Manufacturers
4.2.1 Global L-Glutamine (USP) Revenue by Manufacturers (2020-2025)
4.2.2 Global L-Glutamine (USP) Revenue Market Share by Manufacturers (2020-2025)
4.2.3 Global Top 10 and Top 5 Companies by L-Glutamine (USP) Revenue in 2024
4.3 Global L-Glutamine (USP) Sales Price by Manufacturers (2020-2025)
4.4 Global Key Players of L-Glutamine (USP), Industry Ranking, 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global L-Glutamine (USP) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of L-Glutamine (USP), Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of L-Glutamine (USP), Product Offered and Application
4.8 Global Key Manufacturers of L-Glutamine (USP), Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Sales by Type
5.1.1 Global L-Glutamine (USP) Historical Sales by Type (2020-2025)
5.1.2 Global L-Glutamine (USP) Forecasted Sales by Type (2026-2031)
5.1.3 Global L-Glutamine (USP) Sales Market Share by Type (2020-2031)
5.2 Global Revenue by Type
5.2.1 Global L-Glutamine (USP) Historical Revenue by Type (2020-2025)
5.2.2 Global L-Glutamine (USP) Forecasted Revenue by Type (2026-2031)
5.2.3 Global L-Glutamine (USP) Revenue Market Share by Type (2020-2031)
5.3 Global Price by Type
5.3.1 Global L-Glutamine (USP) Price by Type (2020-2025)
5.3.2 Global L-Glutamine (USP) Price Forecast by Type (2026-2031)
6 Market Size by Application
6.1 Global Sales by Application
6.1.1 Global L-Glutamine (USP) Historical Sales by Application (2020-2025)
6.1.2 Global L-Glutamine (USP) Forecasted Sales by Application (2026-2031)
6.1.3 Global L-Glutamine (USP) Sales Market Share by Application (2020-2031)
6.2 Global Revenue by Application
6.2.1 Global L-Glutamine (USP) Historical Revenue by Application (2020-2025)
6.2.2 Global L-Glutamine (USP) Forecasted Revenue by Application (2026-2031)
6.2.3 Global L-Glutamine (USP) Revenue Market Share by Application (2020-2031)
6.3 Global Price by Application
6.3.1 Global L-Glutamine (USP) Price by Application (2020-2025)
6.3.2 Global L-Glutamine (USP) Price Forecast by Application (2026-2031)
7 US & Canada
7.1 US & Canada Market Size by Type
7.1.1 US & Canada L-Glutamine (USP) Sales by Type (2020-2031)
7.1.2 US & Canada L-Glutamine (USP) Revenue by Type (2020-2031)
7.2 US & Canada Market Size by Application
7.2.1 US & Canada L-Glutamine (USP) Sales by Application (2020-2031)
7.2.2 US & Canada L-Glutamine (USP) Revenue by Application (2020-2031)
7.3 US & Canada Market Size by Country
7.3.1 US & Canada L-Glutamine (USP) Revenue by Country: 2020 VS 2024 VS 2031
7.3.2 US & Canada L-Glutamine (USP) Revenue by Country (2020-2031)
7.3.3 US & Canada L-Glutamine (USP) Sales by Country (2020-2031)
7.3.4 US
7.3.5 Canada
8 Europe
8.1 Europe Market Size by Type
8.1.1 Europe L-Glutamine (USP) Sales by Type (2020-2031)
8.1.2 Europe L-Glutamine (USP) Revenue by Type (2020-2031)
8.2 Europe Market Size by Application
8.2.1 Europe L-Glutamine (USP) Sales by Application (2020-2031)
8.2.2 Europe L-Glutamine (USP) Revenue by Application (2020-2031)
8.3 Europe Market Size by Country
8.3.1 Europe L-Glutamine (USP) Revenue by Country: 2020 VS 2024 VS 2031
8.3.2 Europe L-Glutamine (USP) Sales by Country (2020-2031)
8.3.3 Europe L-Glutamine (USP) Revenue by Country (2020-2031)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Market Size by Type
9.1.1 China L-Glutamine (USP) Sales by Type (2020-2031)
9.1.2 China L-Glutamine (USP) Revenue by Type (2020-2031)
9.2 China Market Size by Application
9.2.1 China L-Glutamine (USP) Sales by Application (2020-2031)
9.2.2 China L-Glutamine (USP) Revenue by Application (2020-2031)
10 Asia (excluding China)
10.1 Asia Market Size by Type
10.1.1 Asia L-Glutamine (USP) Sales by Type (2020-2031)
10.1.2 Asia L-Glutamine (USP) Revenue by Type (2020-2031)
10.2 Asia Market Size by Application
10.2.1 Asia L-Glutamine (USP) Sales by Application (2020-2031)
10.2.2 Asia L-Glutamine (USP) Revenue by Application (2020-2031)
10.3 Asia Market Size by Region
10.3.1 Asia L-Glutamine (USP) Revenue by Region: 2020 VS 2024 VS 2031
10.3.2 Asia L-Glutamine (USP) Revenue by Region (2020-2031)
10.3.3 Asia L-Glutamine (USP) Sales by Region (2020-2031)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Market Size by Type
11.1.1 Middle East, Africa and Latin America L-Glutamine (USP) Sales by Type (2020-2031)
11.1.2 Middle East, Africa and Latin America L-Glutamine (USP) Revenue by Type (2020-2031)
11.2 Middle East, Africa and Latin America Market Size by Application
11.2.1 Middle East, Africa and Latin America L-Glutamine (USP) Sales by Application (2020-2031)
11.2.2 Middle East, Africa and Latin America L-Glutamine (USP) Revenue by Application (2020-2031)
11.3 Middle East, Africa and Latin America Market Size by Country
11.3.1 Middle East, Africa and Latin America L-Glutamine (USP) Revenue by Country: 2020 VS 2024 VS 2031
11.3.2 Middle East, Africa and Latin America L-Glutamine (USP) Revenue by Country (2020-2031)
11.3.3 Middle East, Africa and Latin America L-Glutamine (USP) Sales by Country (2020-2031)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profile
12.1 MeiHua Holdings Group
12.1.1 MeiHua Holdings Group Corporation Information
12.1.2 MeiHua Holdings Group Overview
12.1.3 MeiHua Holdings Group L-Glutamine (USP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.4 MeiHua Holdings Group L-Glutamine (USP) Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 MeiHua Holdings Group Recent Developments
12.2 Ajinomoto
12.2.1 Ajinomoto Corporation Information
12.2.2 Ajinomoto Overview
12.2.3 Ajinomoto L-Glutamine (USP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.4 Ajinomoto L-Glutamine (USP) Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Ajinomoto Recent Developments
12.3 Kyowa Hakko
12.3.1 Kyowa Hakko Corporation Information
12.3.2 Kyowa Hakko Overview
12.3.3 Kyowa Hakko L-Glutamine (USP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.4 Kyowa Hakko L-Glutamine (USP) Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Kyowa Hakko Recent Developments
12.4 Fufeng Group
12.4.1 Fufeng Group Corporation Information
12.4.2 Fufeng Group Overview
12.4.3 Fufeng Group L-Glutamine (USP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.4 Fufeng Group L-Glutamine (USP) Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Fufeng Group Recent Developments
12.5 Daesang
12.5.1 Daesang Corporation Information
12.5.2 Daesang Overview
12.5.3 Daesang L-Glutamine (USP) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.4 Daesang L-Glutamine (USP) Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Daesang Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 L-Glutamine (USP) Industry Chain Analysis
13.2 L-Glutamine (USP) Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 L-Glutamine (USP) Production Mode & Process
13.4 L-Glutamine (USP) Sales and Marketing
13.4.1 L-Glutamine (USP) Sales Channels
13.4.2 L-Glutamine (USP) Distributors
13.5 L-Glutamine (USP) Customers
14 L-Glutamine (USP) Market Dynamics
14.1 L-Glutamine (USP) Industry Trends
14.2 L-Glutamine (USP) Market Drivers
14.3 L-Glutamine (USP) Market Challenges
14.4 L-Glutamine (USP) Market Restraints
15 Key Findings in the Global L-Glutamine (USP) Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global L-Glutamine (USP) market is projected to grow from US$ 195 million in 2025 to US$ 264 million by 2032, at a CAGR of 4.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 127
USD 4900.00
(Single User License)
The global L-Glutamine (USP) market size was US$ 195 million in 2025 and is forecast to reach a readjusted size of US$ 264 million by 2032 with a CAGR of 4.5% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 67
USD 4250.00
(Single User License)
The global market for L-Glutamine (USP) was estimated to be worth US$ 195 million in 2025 and is projected to reach US$ 264 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 83
USD 3950.00
(Single User License)
The global L-Glutamine (USP) market was valued at US$ 195 million in 2025 and is anticipated to reach US$ 264 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 117
USD 2900.00
(Single User License)
The global L-Glutamine (USP) market is projected to grow from US$ 185 million in 2024 to US$ 254 million by 2031, at a CAGR of 4.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 128
USD 4900.00
(Single User License)
The global L-Glutamine (USP) market size was US$ 185 million in 2024 and is forecast to a readjusted size of US$ 254 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-05-30
Pages: 69
USD 4250.00
(Single User License)
The global market for L-Glutamine (USP) was estimated to be worth US$ 185 million in 2024 and is forecast to a readjusted size of US$ 254 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-05-30
Pages: 80
USD 3950.00
(Single User License)
The global market for L-Glutamine (USP) was valued at US$ 185 million in the year 2024 and is projected to reach a revised size of US$ 254 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Published Date: 2025-05-30
Pages: 77
USD 2900.00
(Single User License)
L-Glutamine is a naturally occurring amino acid and the most abundant in the human body. It is categorized as a conditionally essential amino acid, meaning that while the body can normally produce enough, during times of stress, illness, or intense physical activity, supplementation may be necessary.
Published Date: 2024-10-27
Pages: 92
USD 4350.00
(Single User License)
L-Glutamine is a naturally occurring amino acid and the most abundant in the human body. It is categorized as a conditionally essential amino acid, meaning that while the body can normally produce enough, during times of stress, illness, or intense physical activity, supplementation may be necessary.
Published Date: 2024-10-27
Pages: 78
USD 2900.00
(Single User License)
The global L-Glutamine (USP) market is projected to grow from US$ 195 million in 2025 to US$ 264 million by 2032, at a CAGR of 4.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 127
The global L-Glutamine (USP) market size was US$ 195 million in 2025 and is forecast to reach a readjusted size of US$ 264 million by 2032 with a CAGR of 4.5% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 67
The global market for L-Glutamine (USP) was estimated to be worth US$ 195 million in 2025 and is projected to reach US$ 264 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 83
The global L-Glutamine (USP) market was valued at US$ 195 million in 2025 and is anticipated to reach US$ 264 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 117
The global L-Glutamine (USP) market is projected to grow from US$ 185 million in 2024 to US$ 254 million by 2031, at a CAGR of 4.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 128
The global L-Glutamine (USP) market size was US$ 185 million in 2024 and is forecast to a readjusted size of US$ 254 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-05-30
Pages: 69
The global market for L-Glutamine (USP) was estimated to be worth US$ 185 million in 2024 and is forecast to a readjusted size of US$ 254 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-05-30
Pages: 80
The global market for L-Glutamine (USP) was valued at US$ 185 million in the year 2024 and is projected to reach a revised size of US$ 254 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Published: 2025-05-30
Pages: 77
L-Glutamine is a naturally occurring amino acid and the most abundant in the human body. It is categorized as a conditionally essential amino acid, meaning that while the body can normally produce enough, during times of stress, illness, or intense physical activity, supplementation may be necessary.
Published: 2024-10-27
Pages: 92
L-Glutamine is a naturally occurring amino acid and the most abundant in the human body. It is categorized as a conditionally essential amino acid, meaning that while the body can normally produce enough, during times of stress, illness, or intense physical activity, supplementation may be necessary.
Published: 2024-10-27
Pages: 78
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now